Welcome to Business Insider>$4's daily healthcare newsletter>$4, your daily dose of pharma, biotech, and
Hello,
While we wait to hear more about the results of the presidential election, here's the latest in healthcare news.
The promise of the first new Alzheimer's drug in nearly 2 decades
Lydia Ramsey Pflanzer
$4
- What could be the first disease-modifying Alzheimer's drug got a step closer to US approval on Wednesday.
- The US Food and Drug Administration released crucial documents Wednesday summarizing the evidence for and against
Biogen 's experimental treatment called aducanumab. - The FDA documents stated Biogen has "provided substantial evidence of effectiveness to support approval."
- $4
$4
- Health insurance stocks like Cigna and
UnitedHealth Group soared on Wednesday morning, even though the 2020 presidential election remains undecided. - Analysts said it's clear from the election results so far that big healthcare policy changes are unlikely over the next four years.
- $4
$4
- The US reportedly surpassed 103,000 COVID-19 new daily infections on Wednesday, the COVID-19 Tracking Project reported.
- Experts have warned the US is entering the "deadliest" wave of the pandemic as cold weather sets in and people begin hunkering down indoors.
- $4
More stories we're reading:
- Lydia